Patents by Inventor Eamonn Connolly

Eamonn Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
    Publication number: 20100129337
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: January 25, 2010
    Publication date: May 27, 2010
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing inflammation caused by
    Patent number: 7678553
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: March 16, 2010
    Assignee: Biogaia AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
    Publication number: 20090238774
    Abstract: The invention herein relates to the use of nonpathogenic, anti-inflammatory and anti-bleeding lactic acid bacteria strains, and products and methods using such strains for treatment and prophylaxis of bleeding gum and gingivitis caused by oral inflammation.
    Type: Application
    Filed: April 2, 2009
    Publication date: September 24, 2009
    Inventors: EAMONN CONNOLLY, BO MOLLSTAM
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20090123394
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: October 15, 2008
    Publication date: May 14, 2009
    Inventors: Bo Mollstam, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter
    Publication number: 20090110670
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: December 3, 2008
    Publication date: April 30, 2009
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Patent number: 7517681
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: April 14, 2009
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Eamonn Connolly
  • Use of selected lactic acid bacteria for reducing atherosclerosis
    Publication number: 20080254011
    Abstract: Strains of lactic acid bacteria selected for their capability of increasing the BSH-activity and consequently lowering serum LDL-cholesterol, and simultaneously decreasing the pro-inflammatory cytokine TNF-? levels, for prophylaxis and/or treatment of atherosclerosis and other cardiovascular diseases, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: April 11, 2007
    Publication date: October 16, 2008
    Inventors: Peter Rothschild, Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for improving food lysine absorption of pet animals
    Publication number: 20080213431
    Abstract: This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals.
    Type: Application
    Filed: February 26, 2008
    Publication date: September 4, 2008
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of selected lactic acid bacteria for reducing infantile colic
    Publication number: 20080131414
    Abstract: The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 5, 2008
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of selected lactic acid bacteria for reducing infantile colic
    Patent number: 7374924
    Abstract: The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: May 20, 2008
    Assignee: Biogaia AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing inflammation in mammals
    Publication number: 20080107635
    Abstract: Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains
    Type: Application
    Filed: December 24, 2007
    Publication date: May 8, 2008
    Inventor: Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation in mammals
    Patent number: 7344867
    Abstract: Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: March 18, 2008
    Inventor: Eamonn Connolly
  • Use of selected lactic acid bacteria for reducing infantile colic
    Publication number: 20070280913
    Abstract: The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: June 5, 2006
    Publication date: December 6, 2007
    Inventors: Eamonn Connolly, Bo Mollstam
  • Method and use of a lactic acid bacteria with increased acid tolerance
    Publication number: 20070280914
    Abstract: The invention provides certain plasmid cured strains of lactic acid bacteria modified for their capability of better acid-tolerance, a method of modifying such strains, and products containing such strains.
    Type: Application
    Filed: June 5, 2006
    Publication date: December 6, 2007
    Inventor: Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
    Publication number: 20060251636
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: March 31, 2006
    Publication date: November 9, 2006
    Inventors: Eamonn Connolly, Bo Mollstam
  • Method of improving immune function in mammals using lactobacillus strains with certain lipids
    Publication number: 20060251634
    Abstract: A method of improving immune-function in mammals using selected 3-HPA producing lactic acid bacteria with a medium chain triglyceride (MCT) oil.
    Type: Application
    Filed: May 6, 2005
    Publication date: November 9, 2006
    Inventors: Ho-Jin Kang, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation in mammals
    Publication number: 20060233775
    Abstract: Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains
    Type: Application
    Filed: April 15, 2005
    Publication date: October 19, 2006
    Inventor: Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation caused by
    Patent number: 7105336
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: September 12, 2006
    Assignee: Biogaia AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
    Publication number: 20050281756
    Abstract: The invention herein relates to the use of nonpathogenic, anti-inflammatory and anti-bleeding lactic acid bacteria strains, and products and methods using such strains for treatment and prophylaxis of bleeding gum and gingivitis caused by oral inflammation.
    Type: Application
    Filed: June 8, 2005
    Publication date: December 22, 2005
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20050158254
    Abstract: Strains of Lactobacillus that have been selected for their capability of reducing the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with good binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: January 21, 2005
    Publication date: July 21, 2005
    Inventors: Bo Mollstam, Eamonn Connolly